BC
KROS icon

Brookfield Corp’s Keros Therapeutics KROS Stock Holding History

Brookfield Corp’s Portfolio KROS Stock Details KROS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-9,014
Closed -$433K – 710
2022
Q4 		$433K Buy
+9,014
New +$433K ﹤0.01% 528